Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study

被引：0
|
作者：
R Charles Coombes
Christina Angelou
Zamzam Al-Khalili
William Hart
Darius Francescatti
Nicholas Wright
Ian Ellis
Andrew Green
Emad Rakha
Sami Shousha
Hemmel Amrania
Chris C. Phillips
Carlo Palmieri
机构：
[1] Imperial College London,
[2] Rush Medical College,undefined
[3] Barts Cancer Institute,undefined
[4] Nottingham University Hospital,undefined
[5] University of Liverpool,undefined
来源：
Breast Cancer Research and Treatment | 2024年 / 205卷
关键词：
Breast cancer; Prognosis; Mortality; Distant recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：349 / 358
页数：9
相关论文
共 50 条
  • [21] A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma
    Mayer, E. L.
    DeMichele, A.
    Rugo, H. S.
    Miller, K.
    Waks, A. G.
    Come, S. E.
    Mulvey, T.
    Jeselsohn, R.
    Overmoyer, B.
    Guo, H.
    Barry, W. T.
    Bartlett, C. Huang
    Koehler, M.
    Winer, E. P.
    Burstein, H. J.
    ANNALS OF ONCOLOGY, 2019, 30 (09) : 1514 - 1520
  • [22] Prospective Study of the Effect of the 21-Gene Assay on Adjuvant Clinical Decision-Making in Japanese Women With Estrogen Receptor-Positive, Node-Negative, and Node-Positive Breast Cancer
    Yamauchi, Hideko
    Nakagawa, Chizuko
    Takei, Hiroyuki
    Chao, Calvin
    Yoshizawa, Carl
    Yagata, Hiroshi
    Yoshida, Atsushi
    Hayashi, Naoki
    Hell, Susanne
    Nakamura, Seigo
    CLINICAL BREAST CANCER, 2014, 14 (03) : 191 - 197
  • [23] Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?
    Chagpar, Anees B.
    Horowitz, Nina
    Sanft, Tara
    Wilson, Lynn D.
    Silber, Andrea
    Killelea, Brigid
    Moran, Meena S.
    DiGiovanna, Michael P.
    Hofstatter, Erin
    Chung, Gina
    Pusztai, Lajos
    Lannin, Donald R.
    AMERICAN JOURNAL OF SURGERY, 2017, 214 (06) : 1082 - 1088
  • [24] Physical Activity and Survival of Postmenopausal, Hormone Receptor-Positive Breast Cancer Patients Results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle Study
    de Glas, Nienke A.
    Fontein, Duveken B. Y.
    Bastiaannet, Esther
    Pijpe, Anouk
    De Craen, Anton J. M.
    Liefers, Gerrit-Jan
    Nortier, Hans J. W. R.
    de Haes, Hanneke J. C. J. M.
    de Velde, Cornelis J. H. van
    van Leeuwen, Flora E.
    CANCER, 2014, 120 (18) : 2847 - 2854
  • [25] Clinical validation of an immunohistochemistry-based CanAssist-Breast test for distant recurrence prediction in hormone receptor-positive breast cancer patients
    Bakre, Manjiri M.
    Ramkumar, Charusheila
    Attuluri, Arun Kumar
    Basavaraj, Chetana
    Prakash, Chandra
    Buturovic, Ljubomir
    Madhav, Lekshmi
    Naidu, Nirupama
    Prathima, R.
    Somashekhar, S. P.
    Gupta, Sudeep
    Doval, Dinesh Chandra
    Pegram, Mark D.
    CANCER MEDICINE, 2019, 8 (04): : 1755 - 1764
  • [26] Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial
    Leone, Jose P.
    Cole, Bernard F.
    Regan, Meredith M.
    Thurlimann, Beat
    Coates, Alan S.
    Rabaglio, Manuela
    Giobbie-Hurder, Anita
    Gelber, Richard D.
    Ejlertsen, Bent
    Harvey, Vernon J.
    Neven, Patrick
    Lang, Istvan
    Bonnefoi, Herve
    Wardley, Andrew
    Goldhirsch, Aron
    Di Leo, Angelo
    Colleoni, Marco
    Vaz-Luis, Ines
    Lin, Nancy U.
    CANCER, 2021, 127 (05) : 700 - 708
  • [27] Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer
    Cantini, Luca
    Trapani, Dario
    Guidi, Lorenzo
    Bielo, Luca Boscolo
    Scafetta, Roberta
    Koziej, Marcin
    Vidal, Laura
    Saini, Kamal S.
    Curigliano, Giuseppe
    CANCER TREATMENT REVIEWS, 2024, 123
  • [28] The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
    Yuan, Jie
    Yang, Li
    Li, Zhi
    Zhang, Hua
    Wang, Qun
    Huang, Jun
    Wang, Bei
    Mohan, Chakrabhavi Dhananjaya
    Sethi, Gautam
    Wang, Geng
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [29] Impact of adjuvant endocrine therapy on prognosis in small hormone receptor-positive, HER2-negative early breast cancer
    Adachi, Yayoi
    Oze, Isao
    Sawaki, Masataka
    Hattori, Masaya
    Yoshimura, Akiyo
    Kotani, Haruru
    Kataoka, Ayumi
    Sugino, Kayoko
    Horisawa, Nanae
    Ozaki, Yuri
    Endo, Yuka
    Nozawa, Kazuki
    Takatsuka, Daiki
    Iwata, Hiroji
    BREAST CANCER, 2021, 28 (05) : 1087 - 1095
  • [30] Novel Strategies in Hormone Receptor-Positive Advanced Breast Cancer: Overcoming Endocrine Resistance
    Garrido-Castro A.C.
    Metzger-Filho O.
    Current Breast Cancer Reports, 2016, 8 (4) : 193 - 205
12345